The first clinical data on 90 mg eftilagimod was surprisingly effective
“ the biologically, active 30 mg efti dose previously the highest dose of EFTI ever tested demonstrated a stronger immune response in greater efficacy than lower dosing at 1 mg and 6 mg.” The new date suggest that the 30 mg dose maybe too low and even greater responses will be seen with higher dosing.
We ain’t seen nothing yet?
Overnight Market report, page-2574
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |